+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 38 Pages
  • August 2019
  • GlobalData
  • Geovax
  • ID: 4829638
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – A summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotech company that develops human vaccines for human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14, 2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27, 2019: GeoVax reports 2018 year-end financial results

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • GeoVax Labs Inc - Key Facts
  • GeoVax Labs Inc - Key Employees
  • GeoVax Labs Inc - Key Employee Biographies
  • GeoVax Labs Inc - Major Products and Services
  • GeoVax Labs Inc - History
  • GeoVax Labs Inc - Company Statement
  • GeoVax Labs Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 – Company Analysis
  • Company Overview
  • GeoVax Labs Inc - Business Description
  • GeoVax Labs Inc - Corporate Strategy
  • GeoVax Labs Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • GeoVax Labs Inc - Strengths
  • GeoVax Labs Inc - Weaknesses
  • GeoVax Labs Inc - Opportunities
  • GeoVax Labs Inc - Threats
  • GeoVax Labs Inc - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • GeoVax Labs Inc, Recent Deals Summary

Section 4 – Company’s Recent Developments
  • May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention
  • May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
  • May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
  • May 14, 2019: GeoVax Labs announces 2019 first quarter financial results
  • Mar 27, 2019: GeoVax reports 2018 year-end financial results
  • Mar 11, 2019: GeoVax provides product development and corporate update
  • Jan 22, 2019: GeoVax to Present at the 2019 ASM Biothreats Conference
  • Sep 12, 2018: Geovax to report vaccine development progress at the 12th vaccine congress in Budapest
  • Aug 29, 2018: GeoVax Strengthens Scientific Staff and Expertise
  • Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer

Section 5 – Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer

List of Tables
  • GeoVax Labs Inc, Key Facts
  • GeoVax Labs Inc, Key Employees
  • GeoVax Labs Inc, Key Employee Biographies
  • GeoVax Labs Inc, Major Products and Services
  • GeoVax Labs Inc, History
  • GeoVax Labs Inc, Subsidiaries
  • GeoVax Labs Inc, Key Competitors
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • GeoVax Labs Inc, Recent Deals Summary

List of Figures
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Samples

Loading
LOADING...

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • Novavax Inc
  • Sanofi
  • Inovio Pharmaceuticals Inc
  • Merck & Co Inc
  • Profectus BioSciences Inc
  • NewLink Genetics Corp
  • GlaxoSmithKline AG
  • Protein Sciences Corp